Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis. [electronic resource]
Producer: 20180115Description: 47-56 p. digitalISSN:- 1098-8823
- A549 Cells
- Chemokine CXCL1 -- genetics
- Chemokine CXCL2 -- genetics
- Colitis -- chemically induced
- Dextran Sulfate -- adverse effects
- Gene Expression Regulation -- drug effects
- Guanidines -- pharmacology
- Humans
- Phosphotransferases (Alcohol Group Acceptor) -- antagonists & inhibitors
- Sphingosine -- pharmacology
- Tumor Necrosis Factor-alpha -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.